Influenza Vaccine (Split Virion), lnactivated – Anflu®

Influenza Vaccine (Split Virion), lnactivated – Anflu®
Pandemic Influenza Vaccine, lnactivated, Adjuvanted – Panflu®
H1N1 Influenza A Vaccine (Split Virion), lnactivated – Panflu.1®
Influenza Vaccine (Split Virion), lnactivated, Quadrivalent – TetrAnflu®

Anflu®, preservative-free trivalent influenza vaccine, was launched in 2006.

Panflu®, H5N1 flu vaccine, is the first of its kind in China and was approved for national stockpiling in 2008.

Panfu.1®, world's first H1N1 influenza A vaccine, was approved in 2009 and is used for massive inoculation around the world.

TetrAnflu®, quadrivalent influenza vaccine, was launched in 2020:

Provides complete coverage against all four types of influenza viruses and corresponding strains.

Demonstrates a low occurrence of adverse reactions and excellent safety.

Serum protection rates for each type are greater than 90%.